WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009057685) PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/057685    International Application No.:    PCT/JP2008/069736
Publication Date: 07.05.2009 International Filing Date: 30.10.2008
IPC:
A61K 31/426 (2006.01), A61K 31/4725 (2006.01), A61P 13/10 (2006.01), A61P 43/00 (2006.01)
Applicants: Astellas Pharma Inc. [JP/JP]; 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 1038411 (JP) (For All Designated States Except US).
SUZUKI, Masanori [JP/JP]; (JP) (For US Only).
UKAI, Masashi [JP/JP]; (JP) (For US Only).
OHTAKE, Akiyoshi [JP/JP]; (JP) (For US Only)
Inventors: SUZUKI, Masanori; (JP).
UKAI, Masashi; (JP).
OHTAKE, Akiyoshi; (JP)
Agent: MORITA, Hiroshi; c/o Astellas Pharma Inc. Intellectual Property, 3-11 Nihonbashi-Honcho 2-chome Chuo-ku Tokyo 1038411 (JP)
Priority Data:
2007-285802 02.11.2007 JP
Title (EN) PHARMACEUTICAL COMPOSITION FOR TREATING OVERACTIVE BLADDER
(FR) COMPOSITION PHARMACEUTIQUE POUR TRAITER UNE VESSIE HYPERACTIVE
(JA) 過活動膀胱治療用医薬組成物
Abstract: front page image
(EN)It is intended to provide a pharmaceutical composition useful as a therapeutic agent for overactive bladder. The pharmaceutical composition containing (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl}acetanilide or a pharmaceutically acceptable salt thereof and (3R)-quinuclidin-3-yl-(1S)-1-phenyl-1,2,3,4-tetrahydroisoquinoline-2-carboxylate or a pharmaceutically acceptable salt thereof as active ingredients and particularly for improving symptoms accompanying overactive bladder such as urgency of urination, frequent urination, and/or urinary incontinence.
(FR)La présente invention concerne une composition pharmaceutique utile en tant qu'agent thérapeutique pour une vessie hyperactive. La composition pharmaceutique contient du (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phényléthyl)amino]éthyl}acétanilide, ou un sel pharmaceutiquement acceptable de ce composé, et du (3R)-quinuclidin-3-yl-(1S)-1-phényl-1,2,3,4-tétrahydroisoquinoline-2-carboxylate, ou un sel pharmaceutiquement acceptable de celui-ci, en tant qu'ingrédients actifs et elle se révèle particulièrement utile pour améliorer les symptômes accompagnant une hyperactivité de la vessie telle qu'une urgence de miction, des mictions fréquentes et/ou une incontinence urinaire.
(JA)【課題】過活動膀胱治療剤として有用な医薬組成物を提供する。 【解決手段】(R)-2-(2-アミノチアゾール-4-イル)-4'-{2-[(2-ヒドロキシ-2-フェニルエチル)アミノ]エチル}アセトアニリド又はその製薬学的に許容される塩、及び、(1S)-1-フェニル-1,2,3,4-テトラヒドロイソキノリン-2-カルボン酸 (3R)-キヌクリジン-3-イルエステル又はその製薬学的に許容される塩を有効成分とする医薬組成物、特に、尿意切迫感、頻尿、及び/又は尿失禁等の過活動膀胱に伴う諸症状の改善のための医薬組成物。
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)